Koers Nextage Therapeutics Ltd TEL AVIV STOCK EXCHANGE
Aandelen
NXTG
IL0004330119
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Abraham Dreazen
CEO | Chief Executive Officer | 40 | 12-08-20 |
Ishai Gandelsman
DFI | Director of Finance/CFO | 61 | 10-07-22 |
General Counsel | 53 | 12-08-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yaacov Elinav
BRD | Director/Board Member | 79 | 12-08-20 |
Israel Makov
CHM | Chairman | 85 | 21-11-11 |
Ron Grupel
BRD | Director/Board Member | 73 | 13-10-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-40,31% | 8,15 mld. | |
+8,65% | 3,6 mld. | |
-0,25% | 2,27 mld. | |
-24,56% | 1,9 mld. | |
-18,21% | 1,72 mld. | |
+5,95% | 922 mln. | |
+16,75% | 731 mln. | |
-10,48% | 679 mln. | |
-0,60% | 288 mln. |